IL1B and obesity disorder: The inflammation hypothesis suggests that obesity is a chronic inflammatory state, and inflammatory factors such as TNF-α, interleukin-1β (IL-1β), and IL-6 can decrease tissue sensitivity to insulin and lead to pathological changes in pancreatic β-cell function (145).